Stockreport

Investing in Zevra Therapeutics (NASDAQ:ZVRA) three years ago would have delivered you a 63% gain [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF In contrast the stock is up over the last three years. However, it's unlikely many shareholders are elated with the share price gain of 63% over that time, given the ris [Read more]